Artelo biosciences to present at the h.c. wainwright 25th annual global investment conference on september 13th

Solana beach, calif., sept. 05, 2023 (globe newswire) -- artelo biosciences, inc. (nasdaq: artl), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it will be participating in the h.c. wainwright 25th annual global investment conference being held september 11-13, 2023 at the lotte new york palace hotel in new york city.
ARTL Ratings Summary
ARTL Quant Ranking